Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 302.1 | 179.9 | 105.8 |
| Revenue growth | 67.9% | 70.0% | |
| Cost of goods sold | 174.2 | 117.9 | 78.0 |
| Gross profit | 127.9 | 61.9 | 27.8 |
| Gross margin | 42.3% | 34.4% | 26.3% |
| Sales and marketing | 75.4 | 37.6 | 37.0 |
| Research and development | 174.3 | 77.4 | 52.0 |
| General and administrative | 71.6 | 17.9 | 12.2 |
| EBIT | -183.6 | -69.8 | -73.4 |
| EBIT margin | -60.8% | -38.8% | -69.4% |
| Pre-tax income | -174.9 | -66.7 | -70.4 |
| Income taxes | 0.5 | 0.2 | 0.1 |
| Net income | -175.4 | -66.9 | -73.9 |
| Net margin | -58.1% | -37.2% | -69.9% |
| |
| Diluted EPS | ($0.36) | ($0.30) | ($0.33) |
| Shares outstanding (diluted) | 489.1 | 222.0 | 222.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|